ddrg/super_eurlex huggingface dataset:
Official Journal of the European Union

Prior notification of a concentration

(Case M.9776 – Worldline/Ingenico)

(Text with EEA relevance)

(2020/C 273/06)

1. On 12 August 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Worldline S.A. (‘Worldline’, France), — Ingenico Group S.A. (‘Ingenico’, France). Worldline acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of Ingenico. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — for Worldline: payment related services such as merchant acquiring for physical (in-store) or online (e-commerce) businesses, payment processing activities (acquiring and issuing) and e-commerce acceptance solutions, as well as supply of point-of-sale terminals, — for Ingenico: design, development and supply of point-of-sale terminals and related software, as well as payment related services such as merchant acquiring services and e-commerce acceptance services.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9776 – Worldline/Ingenico Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).
Official Journal of the European Union

Prior notification of a concentration

(Case M.9898 – Archer-Daniels-Midland/Marfrig Global Foods/PlantPlus Foods)

Candidate case for simplified procedure

(Text with EEA relevance)

(2020/C 264/04)

1. On 3 August 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Archer-Daniels-Midland Company (‘ADM’, U.S.), public company, — Marfrig Global Foods S.A (‘Marfrig’, Brazil), — PlantPlus Food LLC (‘PlantPlus Food’, U.S.), controlled by ADM and Marfrig. ADM and Marfrig acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of PlantPlus Food. The concentration is accomplished by way of purchase of shares in a newly created company constituting a joint venture.

2. The business activities of the undertakings concerned are: — for ADM: processing of oilseeds, corn, sugar, wheat and other agricultural commodities and a manufacturer of vegetable oils and fats, vegetable protein, meal, corn, sweeteners, flour, biodiesel, ethanol, and other value added food and feed ingredients. ADM has operations globally, — for Marfrig: producing beef and beef patty producer. Marfrig is a leading global producer of meat-based ready-to-eat products such as canned beef, beef jerky, sauces and sachets, — for PlantPlus Food: developing, producing and selling finished beef-like, pork-like and chicken-like vegetable protein based food products.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9898 – Archer-Daniels-Midland/Marfrig Global Foods/PlantPlus Foods Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Non-opposition to a notified concentration

(Case M.9460 – Capgemini/Altran)

(Text with EEA relevance)

(2020/C 284/02)

On 23 October 2019, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32019M9460. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.9868 – Raytheon Technologies Corporation/Saudi Arabian Oil Company/Middle East Cyber Services JV)

(Text with EEA relevance)

(2020/C 278/01)

On 10 July 2020, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32020M9868. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Official Journal of the European Union

Prior notification of a concentration

(Case M.9879 – APG/NPS/JMI/Brisa)

Candidate case for simplified procedure

(Text with EEA relevance)

(2020/C 291/05)

1. On 25 August 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — APG Asset Management N.V. (‘APG’, The Netherlands), — National Pension Service of the Republic of Korea (‘NPS’, Republic of Korea) — José de Mello – Investimentos, SGPS, SA (‘JMI’, Portugal) — Brisa – Auto-Estradas de Portugal, S.A. (‘Brisa’, Portugal) APG, NPS and JMI acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of the whole of Brisa. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — for APG: wholly owned asset management subsidiary of the APG Group, investing funds on behalf of APG Group’s Dutch pension fund in various industries, such as energy and utilities, telecommunications and transport infrastructure, — for NPS: a reserve fund established to finance and execute the National Pension Scheme of the Republic of Korea, managing funds and actively investing in various industries, such as transport infrastructure, on behalf of its clients, — for JMI: a wholly owned subsidiary of the JM Group (Portugal), holding investments in various economic sectors, in particular private healthcare services, road infrastructure and chemical industry mainly in Portugal, — for Brisa: construction, maintenance and operation of motorway concessions, provision of support services to motorway concessions, mobility payment services, technologies for mobility and vehicle services in Portugal.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9879 – APG/NPS/JMI/Brisa Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: E-mail: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Prior notification of a concentration

(Case M.9962 — Mylan/Aspen’s EU Thrombosis Business)

(Text with EEA relevance)

(2020/C 317/08)

Mylan acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of the Target. The concentration is accomplished by way of purchase of assets.

Aspen’s EU Thrombosis Business (the ‘Target’, Mauritius), belonging to the group Aspen Pharmacare Holdings LTD.

On 17 September 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 )

The Target comprises certain commercialisation rights and related intellectual property rights of Aspen’s antithrombotic products in the EEA, namely the molecules Nadroparin (brand names Fraxiparine and Fraxodi), Fondaparinux (brand name Arixtra), Certoparin (brand name Mono Embolex) and Danaparoid (brand name Orgaran).

Mylan develops, licenses, manufactures, markets and distributes generic, branded generic and speciality pharmaceuticals in addition to OTC and consumer healthcare products;

The business activities of the undertakings concerned are:

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.9962 — Mylan/Aspen’s EU Thrombosis Business

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:
Official Journal of the European Union

Prior notification of a concentration

(Case M.9951 – PSPIB/Tishman Speyer/Espace Lumière)

Candidate case for simplified procedure

(Text with EEA relevance)

(2020/C 309/07)

1. On 10 September 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Tishman Speyer Crown Equities 2007 L.L.C. (‘Tishman Speyer’, USA), — Public Sector Pension Investment Board (‘PSPIB’, Canada), — SCI Espace Lumière (‘Target’, France). Tishman Speyer and PSPIB acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of the whole of the Target. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — for Tishman Speyer: ownership, development, fund management and operating of commercial and residential real estate in the United States, Europe, Latin America and Asia, — for PSPIB: management of a diversified global portfolio including stocks and bonds, and investment of net contributions to pension funds under its management in private equity, real estate, infrastructure, natural resources and private debt, — for Target: ownership of a commercial real estate property, Espace Lumière, located in Paris, France.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9951 – PSPIB/Tishman Speyer/Espace Lumiere Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Non-opposition to a notified concentration

(Case M.9905 — Bridgepoint/EQT Credit Platform)

(Text with EEA relevance)

(2020/C 325/03)

On 22 September 2020, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32020M9905. EUR-Lex is the on-line access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Prior notification of a concentration

(Case M.9929 – EDP/Viesgo)

(Text with EEA relevance)

(2020/C 321/07)

EDP acquires within the meaning of Article 3(1)(b) of the Merger Regulation indirect sole control of the whole of Viesgo.The concentration is accomplished by way of purchase of shares.

On 23 September 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 )

for Viesgo: Viesgo’s main activities are the production of electricity from renewable sources in Spain and Portugal and the distribution of electricity in Spain. Viesgo is currently ultimately controlled by Macquarie Infrastructure and Real Assets Europe Ltd. (“MIRAEL”, United Kingdom).

for EDP: EDP is a vertically integrated utility company and the largest generator, distributor and supplier of electricity in Portugal, with significant operations in the electricity sector in Spain. EDP has a worldwide presence, mostly in Portugal, Spain, Brazil and US, being present in 19 countries in 4 continents. EDP is present throughout the electricity value chain and in the gas markets,

The business activities of the undertakings concerned are:

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.9929 – EDP/Viesgo

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:
Official Journal of the European Union

Prior notification of a concentration

(Case M.9875 — BGL BNP Paribas/POST Luxembourg/i-Hub)

Candidate case for simplified procedure

(Text with EEA relevance)

(2020/C 338/05)

1. On 2 October 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — BGL BNP Paribas (‘BGL’, Luxembourg), belonging to the BNP Paribas group (France), — POST Luxembourg (‘POST’, Luxembourg), — i-Hub S.A. (‘I-Hub’, Luxembourg), currently solely controlled by POST. BGL and POST acquire within the meaning of Articles 3(1)(b) and 3(4) of the Merger Regulation joint control of i-Hub. The concentration is accomplished by way of purchase of shares in a newly created company constituting a joint venture.

2. The business activities of the undertakings concerned are: — for BGL: credit institution providing a range of banking services in Luxembourg, including retail banking, international financial services and corporate and institutional banking, — for POST: provider of postal, telecommunication, ICT and banking services in Luxembourg. POST is wholly owned by the Luxembourg State, — for i-Hub: provider of compliance support services, which involve, via its repository platform, assisting undertakings conducting Know Your Customer (‘KYC’) checks in order to comply with their anti-money laundering investigations.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9875 — BGL BNP Paribas/POST Luxembourg/i-Hub Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Official Journal of the European Union

Prior notification of a concentration

(Case M.9960 — KKR/Elsan)

Candidate case for simplified procedure

(Text with EEA relevance)

(2020/C 331/11)

1. On 29 September 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — KKR & Co. Inc. (‘KKR’, USA), — Elsan Holding SAS (‘Elsan’, France) KKR acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of Elsan. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — for KKR: global investment firm, which offers a broad range of alternative asset funds and other investment products to investors and provides capital markets services for the firm, its portfolio companies and third parties. — for Elsan: French hospital care group, which operates clinics throughout France.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9960 – KKR/Elsan Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Non-opposition to a notified concentration

(Case M.9235 — OTPP/MDP/Fleet Complete)

(Text with EEA relevance)

(2020/C 344/05)

On 4 February 2019, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32019M9235. EUR-Lex is the on-line access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.9577 — Genstar/Oak Hill Capital/Mercer ADV)

(Text with EEA relevance)

(2020/C 343/06)

On 16 October 2019, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32019M9577. EUR-Lex is the on-line access to European law.

(1) OJ L 24, 29.1.2004, p. 1.